Pacific Biosciences of California (PACB) Earnings Date, Estimates & Call Transcripts $2.05 +0.09 (+4.59%) (As of 01:33 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Pacific Biosciences of California Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pacific Biosciences of California and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPACB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PACB Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Pacific Biosciences of California Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$0.29-$0.29-$0.29Q3 20241-$0.26-$0.26-$0.26Q4 20241-$0.26-$0.26-$0.2620243-$0.81-$0.81-$0.81Q1 20251-$0.23-$0.23-$0.23Q2 20251-$0.22-$0.22-$0.22 Pacific Biosciences of California Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/7/2024Q2 2024-$0.24-$0.20+$0.04$0.24$40.52M$36.01M5/9/2024Q1 2024-$0.26-$0.26--$0.23$38.78M$38.81M2/15/2024Q4 2023-$0.29-$0.27+$0.02-$0.23$57.96M$58.36M10/30/2023Q3 2023-$0.29-$0.27+$0.02-$0.28$48.76M$55.70M8/2/2023Q2 2023-$0.32-$0.26+$0.06-$0.24$40.12M$47.57M5/2/2023Q1 2023-$0.33-$0.31+$0.02-$0.26$34.38M$38.90MDid You See Trump’s Bombshell Exec. Order 001? (Ad)Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. 2/16/2023Q4 2022-$0.34-$0.35 -$0.01-$0.33$27.29M$27.35M Pacific Biosciences of California Earnings - Frequently Asked Questions How much revenue does Pacific Biosciences of California generate each year? Pacific Biosciences of California (NASDAQ:PACB) has a recorded annual revenue of $200.52 million. How much profit does Pacific Biosciences of California generate each year? Pacific Biosciences of California (NASDAQ:PACB) has a recorded net income of -$306.73 million. PACB has generated -$1.46 earnings per share over the last four quarters. What is Pacific Biosciences of California's EPS forecast for next year? Pacific Biosciences of California's earnings are expected to grow from ($0.90) per share to ($0.65) per share in the next year. More Earnings Resources from MarketBeat Related Companies Harvard Bioscience Earnings Results Thermo Fisher Scientific Earnings Results Agilent Technologies Earnings Results Mettler-Toledo International Earnings Results Illumina Earnings Results Waters Earnings Results Bio-Techne Earnings Results Charles River Laboratories International Earnings Results Bio-Rad Laboratories Earnings Results Bruker Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)The crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most explosive phase of the cycle.>> Register for the Free WaveBot Workshop Now This page (NASDAQ:PACB) was last updated on 12/16/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredMedia Is Mocking Elon, But Wait Until They See This DemoElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredFirst JFK… next Elon?Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. ...Porter & Company | SponsoredWall Street Icon: “If you wait on this, it will already be too late”...Investing legend Louis Navellier warned us about the stock market crash of 1987... the 2000 dot-com crash… Enr...InvestorPlace | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacific Biosciences of California, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacific Biosciences of California With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.